Nomogram for Prediction of Bronchial Mucus Plugs in Children with Mycoplasma pneumoniae Pneumonia.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 03 2020
12 03 2020
Historique:
received:
05
08
2019
accepted:
26
02
2020
entrez:
14
3
2020
pubmed:
14
3
2020
medline:
15
12
2020
Statut:
epublish
Résumé
The presence of bronchial mucus plugs (BMP) in children with Mycoplasma pneumoniae pneumonia (MPP) results in delayed clinical and radiographic resolution and long-standing pulmonary sequelae. The predictive factors associated with BMP formation remains poorly defined. Nomograms to predict BMP presence in children with MPP were proposed using a cohort of patients who underwent bronchoscopy intervention at Children's Hospital in Eastern China. Patients with MPP in an earlier period formed the training cohort (n = 872) for nomogram development, and those thereafter formed the validation cohort (n = 399) to confirmed model's performance. BMP in children with MPP were found in 196 (22.5%) and 91(22.8%) patients in the training and validation cohorts, respectively. The independent risk factors associated with BMP were age >5years (OR 2.06; 95% CI 1.43 to 2.98), higher IL-10 level (>10 ng/L, 2.19; 95% CI 1.46 to 3.28), higher IFN-γ level (>30 ng/L, 1.69; 95% CI 1.13 to 2.54), and presence of complication (3.43; 95% CI 1.45 to 8.09). Incorporating these 4 factors, the nomogram achieved good concordance indexes of 0.771(95% CI, 0.734-0.808) and 0.796 (95% CI, 0.744-0.848) in predicting BMP in the training and validation cohorts, respectively. The nomogram achieved an optimal prediction of BMP in children with MPP. Using this model, the risk of BMP formation would be determined, contributing to a rational therapeutic choice.
Identifiants
pubmed: 32165709
doi: 10.1038/s41598-020-61348-w
pii: 10.1038/s41598-020-61348-w
pmc: PMC7067858
doi:
Substances chimiques
IFNG protein, human
0
IL10 protein, human
0
Interleukin-10
130068-27-8
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4579Références
Ning, G. et al. The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001-2015: A systematic review. Hum. vaccines immunotherapeutics 13, 2742–2750 (2017).
doi: 10.1080/21645515.2017.1371381
Principi, N. & Esposito, S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax 66, 815–822 (2011).
doi: 10.1136/thx.2010.142604
Wallihan, R. & Ramilo, O. Community-acquired pneumonia in children: current challenges and future directions. J. Infect. 69(Suppl 1), S87–90 (2014).
doi: 10.1016/j.jinf.2014.07.021
Sinaniotis, C. A. & Sinaniotis, A. C. Community-acquired pneumonia in children. Curr. Opin. Pulm. Med. 11, 218–225 (2005).
doi: 10.1097/01.mcp.0000159831.82529.85
Xu, Q. et al. Prediction of Bronchial Mucus Plugs Formation in Patients with RefractoryMycoplasma PneumoniaePneumonia. Journal of Tropical Pediatrics, fmw064 (2016).
Zhou, M. et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387, 251–272 (2016).
doi: 10.1016/S0140-6736(15)00551-6
Waites, K. B. New concepts of Mycoplasma pneumoniae infections in children. Pediatr. Pulmonol. 36, 267–278 (2003).
doi: 10.1002/ppul.10346
Griffiths, U. K. et al. Pneumonia Mortality among Children under 5 in China from 1996 to 2013: An Analysis from National Surveillance System. PLoS one 10, e0133620 (2015).
doi: 10.1371/journal.pone.0133620
Huang, L. et al. Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: a prospective cohort study. BMJ open. 8, e023719 (2018).
doi: 10.1136/bmjopen-2018-023719
Akashi, Y. et al. Clinical features and seasonal variations in the prevalence of macrolide-resistant Mycoplasma pneumoniae. J. Gen. family Med. 19, 191–197 (2018).
doi: 10.1002/jgf2.201
Moynihan, K. M. et al. Severe Mycoplasma Pneumoniae Infection in Children Admitted to Pediatric Intensive Care. Pediatr. Infect. Dis. J. 37, e336–e338 (2018).
doi: 10.1097/INF.0000000000002029
Waites, K. B. & Talkington, D. F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17, 697-728, table of contents (2004).
Zhang, Y. et al. Effects of bronchoalveolar lavage on refractory Mycoplasma pneumoniae pneumonia. Respiratory care 59, 1433–1439 (2014).
doi: 10.4187/respcare.03032
Smalley, N., MacLaren, G., Best, D., Paul, E. & Butt, W. Outcomes in children with refractory pneumonia supported with extracorporeal membrane oxygenation. Intensive care Med. 38, 1001–1007 (2012).
doi: 10.1007/s00134-012-2581-5
Efrati, O. et al. Flexible bronchoscopy and bronchoalveolar lavage in pediatric patients with lung disease. Pediatric Crit. Care Med. 10, 80–84 (2009).
doi: 10.1097/PCC.0b013e31819372ea
Ding, Y. et al. High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect. Dis. 18, 439 (2018).
doi: 10.1186/s12879-018-3346-8
Dunican, E. M. et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J. Clin. investigation 128, 997–1009 (2018).
doi: 10.1172/JCI95693
Wang, Z., Li, Y.-C., Zhou, X.-J. & Wu, J.-Y. Prediction of Refractory Mycoplasma Pneumoniae Pneumonia in Pediatric Patients. Pediatric Allergy, Immunology, Pulmonol. 30, 92–96 (2017).
doi: 10.1089/ped.2016.0732
Inamura, N. et al. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. J. Infect. chemotherapy: Off. J. Jpn. Soc. Chemotherapy 20, 270–273 (2014).
doi: 10.1016/j.jiac.2014.01.001
Wang, M. et al. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. Int. J. Infect. diseases: IJID: Off. Publ. Int. Soc. Infect. Dis. 29, 18–23 (2014).
Wang, Y., Zhang, Y., Lu, W. & Wang, L. Serum Tumor Necrosis Factor-alpha and Interferon-gamma Levels in Pediatric Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis. Can. respiratory J. 2018, 8354892 (2018).
Xu, X. F., Li, X. J., Liu, J. L., Wu, L. & Chen, Z. M. Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children. Cytokine 86, 73–78 (2016).
doi: 10.1016/j.cyto.2016.07.018
Kim, Y. et al. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma. JAMA Surg. 151, 365–373 (2016).
doi: 10.1001/jamasurg.2015.4516
Lei, Z. et al. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria. JAMA Surg. 151, 356 (2016).
doi: 10.1001/jamasurg.2015.4257
Steyerberg, E. W. & Vergouwe, Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur. heart J. 35, 1925–1931 (2014).
doi: 10.1093/eurheartj/ehu207
Moons, K. G. M. et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Ann. Intern. Med. 162, W1 (2015).
doi: 10.7326/M14-0698
Smeijsters, K. M. G. et al. Effect of Bronchoscopy on Gas Exchange and Respiratory Mechanics in Critically Ill Patients With Atelectasis: An Observational Cohort Study. Front. Med. 5, 301 (2018).
doi: 10.3389/fmed.2018.00301
Bhat, J. I. et al. Flexible Bronchoscopy in Non-resolving Pneumonia. Indian. J. pediatrics 84, 681–684 (2017).
doi: 10.1007/s12098-017-2372-7
Yang, M. et al. Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children. Sci. Rep. 7, 12934 (2017).
doi: 10.1038/s41598-017-13292-5
Zhang, Y. et al. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children. Sci. Rep. 6, 37037 (2016).
doi: 10.1038/srep37037